Solid Biosciences Inc is a biotechnology company focused on developing innovative therapies for rare genetic diseases, particularly those affecting muscle function, with a strong emphasis on Duchenne muscular dystrophy (DMD)

The company's approach integrates advanced scientific research and clinical expertise to create novel treatments that address the underlying genetic factors of these conditions. Solid Biosciences is committed to collaborating with patients, families, and the scientific community to drive its mission of transforming the lives of individuals affected by muscular dystrophy through groundbreaking therapeutic solutions.